Related Experiment Video
Updated: Jul 14, 2026

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
What is the effect of systemic anticancer treatment on cognitive function?
Alessandro Minisini1, Gul Atalay, Andrew Bottomley
1Unit of Medical Oncology, University of Udine, Italy.
Abstract:
Treatment regimens for solid tumours have been extensively investigated for their physical toxic effects, but far less is known about the potential impairment of cognitive function by anticancer treatment regimens. Here, we review published studies that examined cognitive function in adult patients receiving systemic therapy for solid tumours. Our review suggests that patients can experience cognitive changes related to their treatment. However, several studies had methodological limitations, such as use of a limited sample size, lack of baseline assessment, and lack of control for potential confounding factors. Better designed clinical trials are required so that the difficulties patients face in terms of reduced cognitive function as a result of anticancer treatment can be fully elucidated. These trials should have sufficient statistical power and, importantly, should also be prospective.
Insights
Anticancer treatments may cause cognitive changes in patients with solid tumors. Further research with robust clinical trials is needed to fully understand these cognitive impairments.
Area of Science:
- Oncology
- Neuroscience
- Clinical Trials
Background:
- Physical toxic effects of cancer treatments are well-documented.
- Cognitive function impairment from systemic therapy for solid tumors is less understood.
Purpose of the Study:
- To review published studies on cognitive function in adult patients undergoing systemic therapy for solid tumors.
- To identify the impact of anticancer treatments on cognitive function.
Main Methods:
- Systematic review of published studies.
- Analysis of cognitive function in adult patients with solid tumors receiving systemic therapy.
Main Results:
- Evidence suggests that anticancer treatments can lead to cognitive changes in patients.
- Identified methodological limitations in existing studies include small sample sizes, lack of baseline assessments, and insufficient control for confounding factors.
Conclusions:
- Anticancer treatments pose a risk of cognitive impairment.
- There is a need for well-designed, prospective clinical trials with adequate statistical power to fully elucidate treatment-related cognitive difficulties.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Alzheimer's Disease: Treatment
Therapeutic Drug Monitoring: Affecting Factors

